Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (47,770) $ (55,954)
Reconciling items:    
Depreciation 35,912 33,069
Amortization 64,683 61,886
Deferred income tax expense (benefit) (1,203) (1,698)
Amortization of debt issuance costs, discounts and premium, net 3,121 2,591
Non-cash compensation expense 7,936 8,923
Other, net 492 4,621
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Increase in accounts receivable (6,558) (16,878)
Increase in prepaid expenses and other assets (312,483) (305,294)
Increase in accounts payable, accrued expenses and other liabilities 56,600 79,094
Increase in deferred revenue 959,971 707,038
Net cash provided by operating activities 760,701 517,398
CASH FLOWS FROM INVESTING ACTIVITIES    
Investments made in nonconsolidated affiliates (10,608) (5,165)
Purchases of property, plant and equipment (58,881) (30,681)
Cash paid for acquisitions, net of cash acquired (4,700) (43,378)
Other, net (838) (6,520)
Net cash used in investing activities (75,027) (85,744)
CASH FLOWS FROM FINANCING ACTIVITIES    
Payments on long-term debt (11,775) (9,764)
Distributions to noncontrolling interests (12,227) (15,462)
Proceeds from exercise of stock options 21,628 679
Payments for deferred and contingent consideration (1,074) (15,678)
Other, net (1,618) (13,064)
Net cash used in financing activities (5,066) (53,289)
Effect of exchange rate changes on cash and cash equivalents 20,356 17,791
Net increase in cash and cash equivalents 700,964 396,156
Cash and cash equivalents at beginning of period 1,526,591 1,303,125
Cash and cash equivalents at end of period $ 2,227,555 $ 1,699,281